Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-22 @ 6:43 PM
Study NCT ID:
NCT03915951
Status:
COMPLETED
Last Update Posted:
2025-11-17
First Post:
2019-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-03
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-12
First Submit QC Date:
None
Study First Post Date:
2019-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-18
Results First Submit QC Date:
None
Results First Post Date:
2023-10-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED